Chronic non-specific neck-shoulder pain Signs and Symptoms Pain, not elsewhere classified
Conditions
Interventions
One hundred forty participants with neck-shoulder pain and 40 participants without neck pain will be recruited into this study. The participants without neck pain will be involved in this trial only f
Sponsors
Swedish Council for Working Life and Social Research (Sweden)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Participants with neck-shoulder pain: 1. Women, age 25-65 years 2. Non-specific neck-shoulder pain with a duration of at least 3 months 3. Decreased physical functioning according to the Disability Arm Shoulder Hand (DASH) questionnaire (at least 9 normalised points on 19 selected questions addressing ability to perform all daily activity involving neck, shoulder and arm) Baseline control group: 1. Women, age 25-65 years 2. Healthy volunteers without neck pain
Exclusion criteria
Exclusion criteria: Participants with neck-shoulder pain: 1. Trauma to the head and neck associated with the onset or with any worsening of the symptoms 2. Conditions of rheumatic-, inflammatory- or neurological disease or fibromyalgia 3. Evidence of back-, neck- or shoulder surgery or fracture 4. Cervical rhizopathia 5. Signs of vestibular dysfunction Baseline control group: 1. Trauma to the head, neck or shoulder that has caused considerable problems 2. Conditions of rheumatic-, inflammatory- or neurological disease or fibromyalgia 3. Evidence of back-, neck- or shoulder operation or fracture
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Sensorimotor functioning (Timepoints of assessment: 1 week before start of treatment; 1 week and 6 month after end of treatment): 1.1. Magnitude of fast and slow component of postural sway, calculated from force platform centre of pressure data 1.2. Arm movement precision, measured as end-point precision (variability in horizontal, depth and vertical directions) in a goal-directed arm movement task 2. Self-rated health, symptoms and functioning (Timepoints of assessment: 1 week before start of treatment; 1 week, 6 month, 1 year after end of treatment): 2.1. Nineteen selected questions addressing ability to perform all daily activity involving neck, shoulder, arm and hand from the DASH questionnaire | — |
Secondary
| Measure | Time frame |
|---|---|
| The following will be assessed at 1 week before start of treatment, 1 week and 6 month after end of treatment: 1. Sensorimotor functioning: 1.1. Jerkiness of cervical rotation, calculations based on the "minimum jerk" hypothesis 2. Self-rated health, symptoms and functioning: 2.1. Measurements covering the 4 core chronic pain outcome domains recommended by Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT): a. Pain intensity, assessed by a 0 to 10 numeric rating scale (NRS), 0 = no pain, 10 = worst pain imaginable. b. Physical functioning, assessed by the function index of the Profile Fitness Mapping questionnaire, (under publication), a neck specific questionnaire measuring self-rated functional limitations. c. Emotional functioning, assessed by the Montgomery Åsberg Depression Rating Scale, a questionnaire which has shown high sensitivity to changes in depression. d. Participant ratings of overall improvement, assessed by i) the Patient Global Impression of Change scale and ii) the Profile Fitness Mapping questionnaire - total score, neck-specific symptoms and functional limitations (under publication) 2.2. Fear of movement and re-injury due to movement, assessed by the TAMPA Scale of Kinesiophobia Other outcome measures (these outcome measures will be used in exploratory analyses): 1. Sensorimotor functions: 1.1. Cervikal range of movement. 1.2. Peak velocity of cervical rotation. 1.3. Ankle, hip and neck kinematic coordination during quiet stance 1.4. Arm joint kinematic coordination during goal directed movements 2. Self-rated health, symptoms and functioning: 2.1. Pressure pain threshold, assessed with an algometer, for 3 neck-shoulder points: i) the suboccipital insertion of spinal extensor muscles ii) the trapezius muscle iii) the scapular insertion of the levator scapulae muscle. 2.2. Area of pain distribution, assessed by pain drawings 2.3. Severity of disability assessed by the Neck Disability Index 2. | — |
Countries
Sweden
Outcome results
None listed